Condition: Advanced Systemic Mastocytosis (AdvSM) · SM With an Associated Hematologic Neoplasm (SM-AHN) · Mast Cell Leukemia (MCL) · Sponsor: Cogent Biosciences, Inc.
This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including patients with Aggressive SM (ASM), SM with Associated Hematologic Neoplasm (SM-AHN), and Mast Cell Leukemia (MCL).
This description comes directly from the study's public registry record.
Cogent Biosciences, Inc. · 617-945-5576 · ApexInfo@cogentbio.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham (UAB) Hospital | Birmingham, Alabama, United States | Active Not Recruiting |
| Mayo Clinic Arizona | Phoenix, Arizona, United States | Recruiting |
| City of Hope Comprehensive Cancer Center | Duarte, California, United States | Recruiting |
| UCLA Medical Center | Los Angeles, California, United States | Recruiting |
| Stanford Cancer Institute | Stanford, California, United States | Recruiting |
| Galiz Research | Hialeah, Florida, United States | Withdrawn |
| Winship Cancer Institute - Emory University | Atlanta, Georgia, United States | Recruiting |
| Rush University Medical Center | Chicago, Illinois, United States | Withdrawn |
| Dana-Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
| Columbia University Irving Medical Center | New York, New York, United States | Withdrawn |
| Cleveland Clinic Taussig Cancer Center | Cleveland, Ohio, United States | Active Not Recruiting |
| MUSC Health University Medical Center | Charleston, South Carolina, United States | Recruiting |
+ 30 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04996875